SEARCH BUTTON
HOME > NEWS > New 3D printer at IQS to manufacture arterial models

New 3D printer at IQS to manufacture arterial models

17/12/2021
The IQS Industrial Products Engineering Laboratory equipment has been expanded with the recent incorporation of the Form 3BL 3D printer, for the manufacture of full-scale polymeric arteries.
Nueva impresora 3D en IQS
The new Form 3BL printer in the IQS LEPI laboratory

Thanks to the funding obtained by the Vascular Engineering and Applied Biomedicine Group (GEVAB) within the framework of the CaixaImpulse Consolidate 2020 project, the Industrial Products Engineering Laboratory (LEPI) at the IQS School of Engineering now has the most innovative and complete Formlabs 3D printer: the Form 3BL.

Among many options available, this 3D printer will make it possible to manufacture large medical devices and produce full-scale anatomical models using biocompatible and sterilizable materials. Furthermore, the Form 3BL incorporates the new LFS (Low Force Stereolithography) printing technology which facilitates manufacturing professional quality parts in an academic setting.

Applications of the new Form 3BL

The applications of the Form 3BL are mainly focused on the healthcare sector and medical research.

One of the greatest advantages of this printer is the possibility of manufacturing different aortic dissection models, obtained from images of patients, in a single piece. Thanks to the wide range of printing materials, these models can also be manufactured with flexible, elastic, and transparent materials that will allow the team of researchers from the GEVAB group to conduct tests to develop the medical device they are working on in collaboration with the IQS spinoff Aortyx.

The large dimensions and excellent properties of the 3D aorta models obtained with the new Form 3BL will enable the researchers to test their product in a simulated environment that recreates the actual scenario in which the use of the device is expected as closely as possible.

Therefore, this new acquisition by the LEPI laboratory represents the starting point for the upcoming steps in biomedical research at IQS. This research will undoubtedly be continued in the near future by other groups and sectors that can also benefit from the most advanced 3D printing techniques on the market.

RELATED PEOPLE:

Jordi Martorell López, PhD

Head of GEVAB Group - Assistant Professor
+34932672000
SEE MORE

COLABORATORS

Aortyx

RESEARCH GROUP

GEVAB

Grup d'Enginyeria Vascular i Biomedicina Aplicada

School of Engineering

Vascular Engineering and Applied Biomedicine Group

GEVAB's main objective is to integrate knowledge from medicine, biology, chemistry, physics, mathematics and computing in order to provide solutions to clinical needs.

OTHER RELATED:

Research

Aortyx Receives €2.5 Million Euros from the European Commission’s EIC Accelerator Programme

14/02/2022
The IQS spinoff company, Aortyx, has received €2.5 million euros in "Grant first" funding through the European Innovation Council (EIC) Accelerator Programme. Also, Dr Inés Moreno received one of the prestigious Torres Quevedo Grants at the end of 2021 to conduct her research in this spinoff company.
READ FULL NEW
Research

Development of a new endovascular medical device

26/10/2021
Within the Collaboration Challenges program, Aortyx and the GEMAT group collaborate in the development and preclinical validation of a new endovascular medical device with localized and controlled release of anti-progression drugs for aneurysms.
READ FULL NEW
Research

Adhesive patch for arterial repairs

05/02/2021
IQS researchers of the Endovascular Repair Patch project, carried out within the AGAUR 'Product' call, have achieved both the definitive design of the deployer and the biocompatible materials that allow the administration of a patch for the repair of arteries affected by aortic dissection .
READ FULL NEW